Lyophilized emulsion containing an active substance

Abstract

PCT No. PCT/DE93/01188 Sec. 371 Date Jun. 23, 1995 Sec. 102(e) Date Jun. 23, 1995 PCT Filed Dec. 10, 1993 PCT Pub. No. WO94/13394 PCT Pub. Date Jun. 23, 1994The invention relates to a lyophilized emulsion composition which contains an active substance and which can be redispersed with water to give the original emulsion, and to a process for the preparation thereof. The redispersed emulsion is suitable for parenteral use.

We claim: 
     
       1. An anhydrous emulsion composition comprising at least one active substance, and at least one cryoprotection/bulking agent, wherein after reconstitution with water affords a water-containing emulsion with identical particle size distribution as the original water-containing emulsion. 
     
     
       2. The composition of claim 1 which further comprises hydrophilic emulsifiers and acetylated monoglycerides. 
     
     
       3. The composition of claim 2 wherein the hydrophilic emulsifier comprises ethoxylated triglycerides or polyoxyethylene hydroxy fatty acid esters and the acetylated monoglycerides contain unsaturated double bonds. 
     
     
       4. The composition of claim 2 wherein the hydrophilic emulsifier is glycerol polyethylene glycol ricinoleate or polyoxyethylene 660 12-hydroxystearate and the acetylated monoglycerides are diacetylated monoglycerides or a mixture of diacetylated and partially acetylated monoglycerides. 
     
     
       5. The composition of claim 2 comprising about 2 to 40 wt % acetylated monoglycerides. 
     
     
       6. The composition of claim 5 wherein the acetylated monoglycerides comprise about 20 wt % of partially acetylated monoglycerides. 
     
     
       7. The composition of claim 2 wherein the hydrophilic emulsifiers and the acetylated monoglycerides are present in a weight ratio of about 1:10 to 2:1. 
     
     
       8. The composition of claim 7 wherein said weight ratio is about 2:3. 
     
     
       9. The composition of claim 1 wherein the active substance is a prostaglandin. 
     
     
       10. The composition of claim 9 wherein said prostaglandin is PGE 1 . 
     
     
       11. The composition of claim 1 wherein said cryoprotection/bulking agent comprises physiological tolerated mono-, di- or oligosaccharides. 
     
     
       12. The composition of claim 11 wherein said saccharides are selected from lactose, sorbitol, and mannitol. 
     
     
       13. The composition of claim 1 which further comprises an antioxidant. 
     
     
       14. The composition of claim 13 wherein said antioxidant is α-, β-, Γ-, or δ-tocopherol or a physiologically tolerated buffer salt or mixture thereof. 
     
     
       15. The composition of claim 14 wherein the physiologically tolerated salt is a phosphate, succinate or acetate. 
     
     
       16. The composition of claim 14 wherein the antioxidant is α-tocopherol. 
     
     
       17. The composition of claim 1 wherein said composition, after reconstitution with water, has an average particle diameter of about 0.1 μm to about 3 μm. 
     
     
       18. The composition of claim 17 wherein the average particle diameter is about 0.2 μm to about 1.0 μm.